Meta-analyses show four to six times more retained stomach contents in users, and guidance is moving from blanket pauses toward case-by-case plans.
Recap by typeshit. Full story at Bioengineer.org.
The Times looks at current options for the facial volume loss that can come with rapid GLP-1 weight loss. Full details are on the site.
A Facebook clip has a doctor explaining concerns about muscle loss and hair thinning in people taking GLP-1 medications.
Health NZ is warning that many peptides people inject are unapproved and unregulated, even as demand for the kits keeps growing.
The writer argues the headline merges separate stories, from FDA approval to an 80% visceral fat figure, and says the details don't hold together.
In lab tests the four-amino-acid peptide blocked DPP-IV, an enzyme tied to blood sugar control. The authors say it's unclear whether the body makes enough of it to matter.
Medical Xpress covers work on blocking an enzyme in fat cells, framed against US adult obesity rates above 40% between 2021 and 2023.
Loading…